ANGELALIGN Technology Inc. reported robust interim results for the six months ended 30 June 2026, fueled by accelerated overseas expansion and sustained demand in the Chinese mainland.

Financial Highlights • Revenue climbed 42.90% year-on-year to USD 230.70 million. Overseas markets (ex-Chinese mainland) contributed 51.2% of total revenue, rising 64.8% to USD 118.20 million; Chinese mainland revenue increased 25.4% to USD 112.50 million.

• Gross profit rose 43.80% to USD 144.70 million, lifting gross margin slightly to 62.7% (1H25: 62.4%) on continued cost efficiencies.

• Net profit advanced 79.60% to USD 25.50 million, driving net margin up to 11.0% (1H25: 8.8%). Adjusted net profit, which excludes share-based payments, FX swings, litigation costs and other non-operating items, surged 79.5% to USD 35.00 million, with margin expanding to 15.2% (1H25: 12.1%).

Operational Performance • Total clear-aligner case volume increased 40.2% to 316,609. International case volume jumped 43.4% to 168,001, representing 53.1% of the total; Chinese mainland volumes grew 36.8% to 148,608.

• International operations achieved a first-time segment operating profit of USD 0.60 million versus a USD 5.40 million loss a year earlier. Adjusted operating profit for the segment reached USD 8.80 million (1H25: USD 3.60 million loss).

• Chinese mainland segment operating profit improved 58.2% to USD 27.20 million; adjusted operating profit rose 45.3% to USD 28.60 million.

Cost & Expenses • Selling and marketing expenses grew 30.3% to USD 70.10 million; the ratio to revenue fell to 30.4% (1H25: 33.3%) as scale efficiencies emerged. • R&D spend increased 19.5% to USD 15.30 million, underpinning ongoing product innovation. • Administrative expenses rose 41.7% to USD 31.60 million, including USD 6.80 million of litigation-related costs.

Balance Sheet & Cash Flow • Cash and cash equivalents reached USD 172.53 million (31 Dec 2025: USD 126.71 million); term deposits with initial terms over three months totaled USD 267.83 million. • Net cash from operations more than tripled to USD 53.25 million. • Bank borrowings expanded to USD 71.50 million (31 Dec 2025: USD 2.52 million), lifting the gearing ratio to 17.2%. • Capital expenditure amounted to USD 14.80 million, mainly for manufacturing capacity and IT systems.

Dividends The Board declared an interim dividend of HKD 0.47 per share and a special dividend of HKD 4.10 per share, payable on 25 September 2026 to shareholders on record as of 16 September 2026.

Outlook Management expects continued expansion of clear-aligner adoption, driven by rising demand for complex case solutions and early orthodontic treatment. Key priorities include broadening clinical indications, enhancing global compliance infrastructure, strengthening IP protection, and deepening local professional services as international scale grows.